36C24218R0402-006.pdf

RFP 36C24218R0402

D.9 WORKLOAD HISTORY

Workload Estimates:

As of December 2018, enrollment at the Niagara County/Lockport CBOC is approximately 1,310.

The following is a listing of estimated numbers of veterans residing in Niagara, Erie and Cattaraugus Counties as of 09/30/2018 according to the following website: http://www1.va.gov/vetdata/Veteran_Population.asp

Type User & Enrollee Niagara County

Erie County

Orleans County

Current Users/Enrollees:

2018 P1-6 Users 1,402 450 264

2018 P1-6 Enrollees 4,971 19,331 956

Projected Enrollees:

2019 P1-6 Enrollees 5,010 19,329 955

2020 P1-6 Enrollees 5,042 19,321 958

2021 P1-6 Enrollees 5,056 19,270 956

2022 P1-6 Enrollees 5,047 19,186 954

2023 P1-6 Enrollees 5,025 19,075 950

All these veterans are not actually “enrolled” at VA or a CBOC.

There are eight (8) Priority Groups to which veterans may be assigned after processing. All applications for all eight (8) groups are input into VISTA by the CBOC for reporting and accountability purposes, but those veterans in Priority Group 8, who applied after 1/17/03, are ineligible and will not receive services by the Contractor. Veterans are not "assigned" to a CBOC but may choose either to be seen at VAWNYHS or to be enrolled in a CBOC. The VAWNYHS will notify eligible veterans about the availability of the Lockport CBOC and the services to be provided there. The Government estimates that each patient will make 2.04 visits per contract year to the CBOC.

The numbers of veterans residing in the counties identified above and estimated numbers of visits per patient per year as stated above are estimates only and are to be used for information purposes only. The VA in no way guarantees the accuracy of the estimates. The Contractor fully understands and agrees that costs for any additional visits above the estimated average visits per unique veteran patient and all primary care services as specified in the Performance Work Statement (PWS) are borne by the contractor and is included in the capitation rates agreed to by the contractor in the Schedule of Services/Price/Costs section.

Patients have the right to receive primary care other than from the VAWNYHS or a VAWNYHS CBOC. The VA, however, encourages patients to have only one primary care provider; and it is the VAWNYHS’s expectation that the patient is seen at the Lockport CBOC at least once per twelve (12) month period or as often as deemed clinically appropriate by the veteran’s VHA CBOC primary care provider (for further guidance, please also refer to VHA Directive 2009-038 dated August 25, 2009, which is available at http://vaww1.va.gov/vhapublications/ViewPublication.asp?pub_ID=2058).

Statistical Information:

The Niagara County/Lockport CBOC has been in operation since 1999.

The following is the most recent statistical information for services provided for the Niagara County/Lockport CBOC for the period of 10/01/2017 - 09/30/2018 (FY 18). Please note, all data provided is for informational purposes only and does not represent any guarantee.

For Reference:

• Unduplicated Encounters: An unduplicated count of clinic stops where duplicates have been removed. A duplicate clinic stop occurs when a patient makes more than one of the same type of PRIMARY clinic stop at the same substation on the same day.

http://www1.va.gov/vetdata/Veteran_Population.asp http://vaww1.va.gov/vhapublications/ViewPublication.asp?pub_ID=2058

• Encounter: An encounter is a professional contact between a patient and a practitioner vested with primary responsibility for diagnosing, evaluating, and/or treating the patient’s condition. Encounters occur in both the outpatient and inpatient setting. Contact can include face-to-face interactions or those accomplished via telemedicine technology).

FY 18 Visits & Encounters per Unique Outpt by VISN

FY 18 Age & Sex Distribution (1V02) (528GK) Lockport, NY

FY 18 Most Frequent ICD Diagnoses

FY 18 Estimated Medication & Immunization Utilization

Item Name Qty

ALBUTEROL SOLN 0.083% (PREMIX) 2.5MG/3ML (PROVENTIL) (3 mL) SOLN INHL 8

ARIPIPRAZOLE SA (400MG/VIAL) (ABILIFY MAINTENA) INJ SUSP 4

ASPIRIN (ASA) 325 mg TAB 4

CYANOCOBALAMIN (Vitamin B12) 1000 mcg/1 mL (1 mL) INJ VIAL 44

DIPHENHYDRAMINE CBOC (40's) (BENADRYL) 25 mg CAP ORAL 4

DIPHTHERIA (2 UNITS)/TETANUS (5 UNITS) TOXOID ADSORBED (TENIVAC (Td)) (0.5 mL) INJ SYRINGE 44

HEPATITIS A 720 EL U/HEPATITIS B 20 MCG VACCINE (TWINRIX) (1 mL) INJ SYRINGE 56

HEPATITIS A VACCINE INACTIVE (HAVRIX) 1440 unit/1 mL INJ 4

HEPATITIS B VACCINE (RECOMBINANT) (ENGERIX-B) 20 mcg/1 mL (1 mL) INJ VIAL 32

IBUPROFEN CBOC 40's (MOTRIN) 600 mg TAB 20

INFLUENZA VACC,TRIVAL,ADJ (PF) (FLUAD) INJ 380

INFLUENZA VACCINE,QUAD (PF) SYR (AFLURIA) (0.5 mL) INJ SYRINGE 230

MEDROXYPROGESTERONE ACETATE CBOC (Depo-subQprovera) 104 mg/0.65 mL (0.65 mL) INJ SYRINGE 8

NALOXONE (EQV-NARCAN) (NARCAN) 0.4 mg/1 mL (1 mL) INJ VIAL 4

PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (PREVNAR 13 VACCINE) (0.5 mL) INJ SYRINGE 40

PNEUMOCOCCAL 23-VALENT VACCINE (PNEUMOVAX-23) (0.5 mL) INJ SYRINGE 116

PNEUMOCOCCAL 23-VALENT VACCINE (PNEUMOVAX-23) INJ 120

TETANUS/DIPHTHERIA/PERTUSSIS VACCINE ((Tdap) (BOOSTRIX)) (0.5 mL) INJ SYRINGE 84

TUBERCULIN, PPD (APLISOL) 5 unit/0.1 mL INJ SOLN 80

ZOSTER VACCINE RECOMBINANT (SHINGRIX) (0.5 mL) INJ VIAL 180

*Note: This information is provided for informational purposes only – patient care needs may dictate a requirement for other medications or immunizations, which will be the Contractor’s responsibility. The Contractor is responsible for all medications and immunizations that are to be administered in clinic.